Back row (left to right): Daisy Nash, PharmD, PGY1 pharmacy resident; Andy Tsai, PharmD, PGY2 pediatric resident; Emma Fleck, PharmD, PGY1 pharmacy resident; Kali Cira, PharmD, PGY1 pharmacy resident. Front row (left to right): Rachel Bonin, PharmD, PGY2 oncology resident; Rachel Dittrich, PharmD, PGY2 pediatric resident
Welcome to our informational page on pharmacy residency training! Our institution currently offers three residency programs:
Our pages offer guidance on requirements for these programs in addition to background on offered rotations, longitudinal experiences and research.
We champion anti-racism and find strength in the diversity of our patients, their families, staff and community. We believe all children deserve exceptional care, the best outcomes, respect and a safe environment. To achieve this, we work to eliminate health inequities and address any form of systemic racism in our organization. Our residency program includes opportunities to serve in this mission.
Evan Abrass, PharmD, BCOP
Hematology/Oncology and Bone Marrow Transplant
PGY2 Oncology Residency Program Director
Adam Brothers, PharmD
Antimicrobial Stewardship
Anny Chan, PharmD
Bone Marrow Transplant
Hannah Christensen, PharmD, BCPP
Pediatric and Adolescent Psychiatry
Andrea Ewing, PharmD
Pharmacy Operations Educator
Alina Herman, PharmD, BCPS
Bone Marrow Transplant
Karyl Kanada, PharmD
Emergency Medicine
Sai Karwande, PharmD, BCCCP
Pediatric Intensive Care
Lisa Knorr, PharmD, BCPS, BCCCP
Cardiac Solid Organ Transplant and Heart Failure
Cardiac Intensive Care Unit
William Korab, PharmD, BCPS
Pediatric General Medicine
Dominique Mark, PharmD, BCPS, BCPPS
Residency Program Director, PGY1 Pharmacy and PGY2 Pediatrics
Pediatric General Medicine
Kris Martinson, PharmD
Hematology/Oncology Pharmacist
Tom Nemeth, PharmD
Cardiac and Abdominal Solid Organ Transplant
David Newland, PharmD, BCPS, BCTXP
Heart Center Lead Pharmacist
Cardiac Solid Organ Transplant
Jennifer Nguyen, PharmD
Pediatric General Medicine
Jenna Nickless, PharmD, BCCCP
Pediatric and Cardiac Intensive Care
Dan Pak, PharmD
Antimicrobial Stewardship and NICU
Jennifer Pak, PharmD, CACP
Anticoagulation CDTA Pharmacy Lead
Esther Park, PharmD, BCPPS
Pharmacy, Quality, and Medication Safety Manager
Ana Petrovic, RPh
Pediatric General Medicine
Amber Pulido, PharmD, BCPS, BCNSP
TPN CDTA Pharmacy Lead
Neonatal Intensive Care
Jenni Rasiah, PharmD
Pediatric General Medicine
Kyle Roberts, PharmD, BCPS, BCPPS, BCCCP
Neonatal and Cardiac Intensive Care
Beatrice Rosete, PharmD
Liver and Abdominal Transplant
Christy Smith, PharmD, BCPPS, BCCCP
Pediatric Intensive Care
Nina Srour, PharmD, BCCCP
Cardiac Intensive Care
Dave Villeneuve, PharmD
Pediatric General Medicine
Laura Walsh, PharmD, BCPS, BCPPS
Emergency Medicine
Rebecca Wilke, PharmD
Pediatric General Medicine
|
Residency Year |
Name of Resident |
Residency Project |
Current Position |
|---|---|---|---|
|
2006-2007 |
Julie Ryu |
Established pilot ambulatory solid organ transplant.
|
Gilead Sciences, Senior Manager, Medical Affairs |
|
2007-2008 |
Tsingyi Koh
|
Effectiveness of a Pharmacist initiated antimicrobial management program in a pediatric teaching hospital. |
National University Hospital Singapore, Principal Clinical Pharmacist (Solid Organ Transplant/Pediatrics) |
|
2007-2008 |
Nicole Richardson |
Defining the Role of a Clinical Pediatric Emergency Department Pharmacist. |
Kootenai Health, Clinical Pharmacist |
|
2008-2009 |
Kristina M. Gonzalez |
Assess if a transitional program will have an impact on rejection episodes in the adolescent population. |
Christus Health: PGY1 Pharmacy Residency Coordinator |
|
2008-2009 |
Jennifer Nguyen |
Evaluation of Pharmacist Managed Enoxaparin in Pediatric Patients. |
Seattle Children’s Hospital, General Pediatrics, Clinical Pharmacist |
|
2009-2010 |
David Villeneuve |
Valganciclovir Kinetics in Solid Organ Transplanted Infants and Young Children. Villeneuve D, Brothers A, Harvey E, et al. Valganciclovir dosing using area under the curve calculations in pediatric solid organ transplant recipients. Pediatr Transplant. 2013;17(1):80‐85. doi:10.1111/petr.12030 |
Seattle Children’s Hospital, General Pediatrics, Clinical Pharmacist |
|
2009-2010 |
Sarah Tucker |
Effect of Pharmacist Provided Education on Family Confidence in Managing Common Chemotherapy Complications. |
Seattle Children’s Hospital, Oncology Beacon/Informatics Pharmacist (until 2024) |
|
2010-2011 |
Sarah Chumbley |
A pharmacist-run monitoring program for tobramycin in pediatric patients with cystic fibrosis. |
Seattle Children’s Hospital, Intensive Care, Clinical Pharmacist (until 2023) |
|
2010-2011 |
Katie Bridger |
An Analysis of Implementing a Status Epilepticus Algorithm in a Pediatric Emergency Department. |
Seattle Children’s Hospital, Pharmacy Operations and Distribution Pharmacist |
|
2011-2012 |
Jennifer Welsh |
The Physical and Chemical Stability of Iron Sucrose in Parenteral Nutrition for patients with Intestinal Failure.
|
Womack Army Medical Center, Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist. |
|
2011-2012 |
Bradley Mirashiro |
The impact of a clinical pharmacist presence in the pediatric inpatient psychiatry unit.
|
CVS Honolulu, Pharmacist |
|
2012-2013 |
Joanna Collins |
A Retrospective Analysis to Identify Factors Associated with Acute Kidney Injury in a Tertiary Pediatric Hospital. |
Seattle Children’s Hospital, Pharmacy Quality Safety Team, Pharmacist (until 2021) |
|
2012-2013 |
Melissa Sandley (Rees) |
Therapeutic Drug Monitoring in Pediatric Voriconazole Dosing |
Oregon Health and Science University (OHSU) Pediatric Hematology/Oncology and Bone Marrow Transplant Pharmacist |
|
2013-2014 |
Jennifer Rasiah (Higuchi) |
Use of gastric acid suppressants by pediatric inpatients transferred out of the intensive care unit |
Seattle Children’s Hospital, General Pediatrics, Clinical Pharmacist |
|
2013-2014 |
Esther Park |
Vitamin D Supplementation in Adolescent Nonadherent CF Patients.
|
Seattle Children's Hospital, Manager, Pharmacy Quality Safety & Compliance |
|
2014-2015 |
Victoria Chadwick |
Standardizing clonidine use for dexmedetomidine withdrawal in pediatrics |
Swedish Medical Center, General Pediatrics and ICU, Clinical Pharmacist |
|
2014-2015 |
Rebecca Wilke |
Evaluation of vancomycin use in the pediatric intensive care unit of a large pediatric referral hospital |
Seattle Children’s Hospital, General Pediatrics, Clinical Pharmacist |
|
2015-2016 |
Matt Stephens |
Impact on Acute Otitis Media Antibiotic Orders from Auralgan Market Removal |
Seattle Children’s Hospital, ICU Supervisor and Clinical Pharmacist |
|
2015-2016 |
Anna Zhen |
Impact of a Revised Approach to Documentation and Evaluation of Penicillin and Cephalosporin Allergies in Pediatric Patients |
Lucile Packard, General Medicine, Clinical Pharmacist |
|
2016-2017 |
Ana Petrovic |
Retrospective Review of High vs. Standard Infliximab Dose in the Treatment of Pediatric Acute Ulcerative Colitis |
Seattle Children’s Hospital, General Pediatrics, Clinical Pharmacist |
|
2016-2017 |
Ronika Kalpage |
Vancomycin Area Under the Curve Monitoring in Pediatric Hematology, Oncology, and Bone Marrow Transplant Patients. |
Sutter Sacramento Women and Children’s Center, Clinical Pharmacist |
|
2017-2018 |
Jenna Nickless |
Evaluation of intravenous posaconazole dosing and pharmacokinetic target attainment in pediatric patients. Nickless JR, Bridger KE, Vora SB, Brothers AW. Evaluation of Intravenous Posaconazole Dosing and Pharmacokinetic Target Attainment in Pediatric Patients. J Pediatric Infect Dis Soc. 2019;8(4):365‐367. doi:10.1093/jpids/piy094 |
Seattle Children’s Hospital, Intensive Care, Per Diem, Clinical Pharmacist |
|
2017-2018 |
Macy Miller (Royston) |
Retrospective analysis of rabbit anti-thymocyte globulin versus basiliximab induction in pediatric liver transplant recipients. Newland DM, Royston MJ, McDonald DR, et al. Analysis of rabbit anti-thymocyte globulin vs basiliximab induction in pediatric liver transplant recipients. Pediatr Transplant. 2019;23(8):e13573. doi:10.1111/petr.13573 |
University of Minnesota Medical Center, Pediatric Clinical Pharmacist |
|
2018-2019 |
Paul Paratore |
Neutropenia in Pediatric Patients Receiving High-Dose Cephalexin: A Retrospective Analysis. |
Denver Health, Pediatric Clinical Pharmacist |
|
2018-2019 |
Emilie Lynch (Bergsma) |
Comparison of Argatroban and Heparin in Pediatric Patients: A Retrospective Case Controlled Review.
|
University of Florida (UF) Health Shand’s Children’s Hospital, Pediatric Hematology/Oncology/BMT Clinical Pharmacist Specialist |
|
2019-2020 |
Karyl Kanada |
Implementation of a Multidisciplinary Intravenous Immunoglobulin Guideline of Care for Chylothorax in Infants Following Cardiac Surgery: Infection Rates and Associated Costs. |
Seattle Children’s Hospital, Emergency Medicine Clinical Pharmacist |
|
2019-2020 |
Annie Park |
Enoxaparin Anti-Xa Monitoring Protocol in Hospitalized Pediatric Patients. |
Mary Bridge Children’s Hospital, Pediatric Hematology/Oncology Pharmacist |
|
2020-2021 |
Josh DeGrave |
Standardized Pharmacy-Driven Opioid Taper Guideline In Pediatric Acute Care. |
University of Wisconsin (UW) Health, Pediatric Clinical Pharmacist |
|
2020-2021 |
Grant Mason |
Implementation of a Therapeutic Drug Monitoring Protocol for Beta-Lactam Antibiotics in Pediatric Patients |
Children’s Hospital of LA (CHLA), Pediatric Clinical Pharmacist |
|
2021-2022 |
Filmon Emnetu |
Oral Amoxicillin Challenge for Penicillin Allergy De-Labeling in Pediatric Patients. |
Eli Lilly and Company, Clinical Trial Project Manager |
|
2021-2022 |
Sonya Barich |
Characterization of Triazole Antifungal Collaborative Practice Agreement Implementation in Pediatric Oncology Patients |
Seattle Children’s Hospital, Hematology Oncology Pharmacist |
|
2022-2023 |
Alexis Perry |
Differences in the Incidence of Clostridioides difficile associated diarrhea in pediatric hematology and oncology patients with ceftazidime or cefepime. |
Children’s Healthcare of Atlanta, Hematology Oncology and Bone Marrow Transplant Pharmacist |
|
2022-2023 |
Tracy Liu |
Evaluation of a Beta Lactam Therapeutic Drug Monitoring Protocol in Critically Ill Children on CRRT or ECMO |
Seattle Children’s Hospital, Clinical Float Pharmacist |
|
2022-2023 |
Leah Burns |
Interval Training: A Quality Improvement Initiative for Extended Interval Aminoglycoside Therapy in Pediatric Patients |
LeBonheur Children’s Hospital, General Pediatrics, Clinical Pharmacist |
|
2023-2024 |
Kiara Light |
Bivalirudin Initial vs. First Therapeutic Infusion Rate |
Oregon Health and Science University (OHSU), General Pediatrics, Clinical Pharmacist |
|
2023-2024 |
Rachel Bonin |
Evaluation of Adverse Effects Associated with Undiluted Levetiracetam in Pediatric Status Epilepticus Patients in the Emergency Department |
Seattle Children’s Hospital, PGY2 Hematology Oncology Resident |
|
2023-2024 |
Michelle Palmer |
Optimization of Pharmacist Led IV to PO Therapeutic Interchange |
Seattle Children’s Hospital, Pharmacy Operations and Distribution Pharmacist |
|
2023-2024 |
Jasmine Gronek |
Optimization of Standardized Dosing of Pediatric Dosage Forms |
University of North Carolina, Chapel Hill, General Pediatrics, Clinical Pharmacist |
|
2023-2024 |
Katie McFarland |
Beta Lactam Therapeutic Drug Monitoring in Pediatric Patients on Extracorporeal Therapy |
Children’s Hospital of Colorado, General Pediatrics Float, Clinical Pharmacist |